SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Advanced Viral Research CP (ADVR)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: .com who wrote (1846)12/10/1996 3:51:00 PM
From: Bernie Bildman   of 2281
 
Scott, what we're looking for is test results that will be impressive enough for the FDA to allow human testing in this country. The results are basically saying the blood levels of certain substances that are used to measure the body's ability to respond the the virus' demand on the immune system have been stimulated.

What we're hoping for is MORE testing, in this country, that will either prove or disprove Reticulose's efficacy. Once that is established, you will see major movement in prices. Each positive news release that brings us closer to that will bring us closer to a company that has future profits.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext